The risk of death was substantially lower among patients with dMMR/MSI-H disease (HR 0.32; 95% CI 0.17–0.63), while a favorable trend toward improved overall survival was observed in the pMMR/MSS population (HR 0.79; 95% CI 0.60–1.04) ( Powell et al., 2024 ).
← all excerpts
Immunotherapy related organizing pneumonia mimicking metastatic progression in a patient with endometrial cancer: A case report.
1
—
—